dna-istock-518143098-ralwel--2
ralwel / iStockphoto.com
10 April 2018Americas

Novartis signs $8.7bn gene therapy deal

Swiss drug maker Novartis is set to strengthen its gene therapy expertise with the $8.7 billion addition of Nasdaq-listed AveXis to its portfolio.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.